Fact-checked by Grok 2 weeks ago

David Sanders

David Sanders is an biologist and of biological sciences at , specializing in molecular with research focused on the mechanisms of enveloped virus entry into host cells, including retroviruses, and the development of modified viruses for applications. His has advanced understanding of functions, such as determining the of a key protein to enable potential treatments for various diseases, and explored enzymatic modifications of viruses to facilitate safe . Sanders has also contributed to preparedness through consulting on coronaviruses, vaccines, and antivirals. Beyond research, Sanders has gained prominence as a scientific integrity advocate, systematically identifying image manipulation, data irregularities, and other forms of in peer-reviewed papers, contributing to numerous retractions and investigations, including high-profile cases like the 2010 "arsenic life" controversy and allegations against prominent researchers. This work led to a against him by a researcher whose papers he critiqued, which Sanders won, underscoring tensions between whistleblowers and academic institutions amid funding pressures that incentivize questionable practices. He has emphasized that exposing preserves scientific credibility, arguing that perpetrators, not critics, undermine the field. Additionally, Sanders has engaged in academic governance as chair of Purdue's University and local politics, serving on the West Lafayette City Council and running unsuccessfully for the State in , where he advocated evidence-based policies.

Early life and education

Childhood and early influences

Sanders was born and raised in , a suburban community in Bergen County. His family resided in this middle-class area, which provided a stable environment conducive to personal development during his formative years. Teaneck's proximity to offered access to cultural and educational resources, potentially fostering early intellectual curiosity, though specific family dynamics remain undocumented in public records. From 1976 to 1979, Sanders attended the in , , a prestigious independent preparatory institution known for its emphasis on academic excellence and . The school's rigorous curriculum and small class sizes exposed him to high standards of scholarship from an early age, including advanced studies in sciences that may have sparked his later pursuits in . During this period, he served as president of a , indicating early involvement. While direct accounts of childhood influences on his scientific interests are limited, Sanders' transition from a suburb to an elite urban preparatory school suggests a foundation in environments valuing education and , setting the stage for his focus on empirical disciplines without extending into formal . No verifiable personal anecdotes detail specific events or mentors from this era that directly prompted his engagement with or .

Academic background

David Sanders earned a degree in molecular biophysics and biochemistry from . He completed a Ph.D. in biochemistry at the , in 1989, with his dissertation examining a key biochemical reaction enabling bacterial adaptation to environmental changes. After his doctoral studies, Sanders worked as a visiting scientist at the , investigating signal-transducing . He then pursued postdoctoral fellowship at the Whitehead Institute for Biomedical Research, affiliated with the , where he began exploring viral entry mechanisms into host cells, including pathways for inhibiting infection and potential uses in . This training laid the groundwork for his subsequent specialization in molecular .

Professional career

Academic appointments

Sanders joined the faculty of Purdue University's Department of Biological Sciences in 1995, initially affiliated with the Markey Center for . He progressed to the rank of , a position he has held while directing the university's molecular research efforts. In this capacity, Sanders maintains professional faculty research status, overseeing the Sanders Laboratory dedicated to studies, ensuring continuity in programmatic leadership within the department. His appointment includes involvement in the Markey Center's initiatives, where he contributed to program coordination without specified shifts in tenure-track status.

Teaching and administrative roles

Sanders has taught undergraduate and graduate courses in the Department of Biological Sciences at , specializing in and related topics. He instructs BIOL 595, a graduate-level course on molecular , covering mechanisms of viral entry and replication. Additionally, he developed and taught BIOL 31800, an undergraduate course titled "The ," which examines the outbreak, extending into implications beyond core and . In mentorship, Sanders has supervised undergraduate students in projects focused on structural virology, providing hands-on training in lab techniques and within his group. His role includes guiding students and postdoctoral researchers to enhance their skills, though specific outcomes in contexts remain documented primarily through departmental records rather than independent achievements. Administratively, Sanders has served on multiple university committees, including the Senate Faculty Affairs Committee and as chair of the Committee, advocating for policies affecting students, faculty, and staff. He previously chaired the University Senate steering committee and contributed to the College of Science Faculty Council and Undergraduate Curriculum and Academic Policy Committee, influencing academic governance and curriculum standards. These roles underscore his involvement in departmental and institutional initiatives aimed at maintaining educational integrity and operational efficiency.

Scientific research

Core focus on virology

David Sanders' research in molecular primarily investigates the entry mechanisms of retroviruses and other enveloped viruses into host cells, emphasizing the molecular interactions that enable viral attachment, , and internalization. This includes detailed analysis of surface glycoproteins from viruses such as lentiviruses, alphaviruses, and Ebola virus, which mediate binding to host receptors and subsequent events. His approach highlights the critical role of protein-protein interactions at the viral-host interface, providing foundational insights into the initial stages of infection. A key theme in Sanders' work is the enzymatic processing underlying viral entry, particularly phosphoryl transfer mechanisms that regulate conformational changes in envelope proteins necessary for penetration of cellular barriers. By employing methodologies like the construction of pseudotyped viral particles—combining core proteins from retroviruses or lentiviruses with heterologous envelope glycoproteins—his laboratory dissects these processes without relying on live pathogens, allowing controlled examination of entry dynamics across diverse enveloped viruses. This systematic dissection underscores causal pathways in infection, from receptor engagement to post-fusion states. These investigations carry implications for comprehending in diseases driven by such viruses, including (a ) and Ebola virus-induced hemorrhagic fevers, as well as zoonotic transmissions from animal reservoirs like birds to humans. Understanding these entry fundamentals informs strategies for blocking infection at early stages, aligning with broader virological goals of and prevention of viral spread. Sanders' emphasis on empirical dissection of these mechanisms prioritizes verifiable biochemical and structural data over speculative models.

Key discoveries and publications

Sanders' doctoral research at the elucidated the role of proteolytic cleavage in the cytoplasmic domain of the envelope protein, demonstrating that such processing activates the fusion-competent conformation necessary for efficient retroviral entry into host cells. This finding, detailed in early publications in the Journal of Virology, provided mechanistic insights into enveloped virus assembly and infectivity, influencing subsequent models of retroviral membrane fusion. Building on this, Sanders advanced pseudotyping strategies for retroviral vectors, incorporating heterologous envelope glycoproteins to broaden tissue tropism for . Notable contributions include the development of vectors pseudotyped with envelopes, such as Sindbis and glycoproteins, which enhanced efficiency in non-dividing cells, as reported in a 2005 Journal of Virology study on HIV-1 vectors. Similarly, his 2002 work in Human Gene Therapy addressed premature fusion issues in novel pseudotypes, enabling safer and more effective vector design. In , Sanders identified critical residues in the virus glycoprotein GP1 domain that govern receptor binding and post-binding entry steps, published in a 2007 Journal of Virology paper co-authored with W. Maury; these findings clarified receptor interactions and informed antiviral targeting strategies. More recently, a 2019 Virology publication from his lab delineated the role of in the entry and egress of glycoprotein-pseudotyped vectors, highlighting dependencies in alphavirus-host interactions. Sanders also contributed to structural biology with the 2006 determination of the Escherichia coli exopolyphosphatase crystal structure, revealing a novel bisubstrate mechanism for phosphoryl transfer that positions the enzyme as a potential antibiotic target against bacterial stress responses, including those evading host immunity during viral co-infections. This work, leveraging , underscored polyphosphate metabolism's vulnerability in pathogens.

Contributions to gene therapy

Sanders' contributions to primarily involve the engineering of pseudotyped viral vectors to achieve targeted and efficient delivery of therapeutic genes into mammalian cells. In 2001, collaborating with , he developed a pseudotyped by substituting the standard retroviral envelope with an alphavirus coat protein, such as from , which expanded the vector's to a wider range of cell types while ensuring stable, permanent gene integration without cytotoxicity associated with alternatives like VSV-G pseudotypes. This system, detailed in a March 2001 Journal of Virology publication, supports indefinite production of viral particles in stable cell lines and targets applications in treating genetic deficiencies, cancer, and , prompting to file a corresponding . His innovations extend to exploiting virus glycoproteins () as retargeting elements for lentiviral and retroviral vectors, harnessing the GP's membrane fusion capabilities to direct cargoes while restricting off-target entry. A 2004 study demonstrated that pseudotyping with modified GP—lacking the O-glycosylation —enabled effective of airway epithelial cells, a critical advancement for by facilitating precise delivery of corrective nucleic acids. This work bridges viral entry research with therapeutic vector design, emphasizing modifications that enhance specificity and reduce . Sanders' laboratory has further refined hybrid vectors combining retroviral or lentiviral interiors with exteriors to access challenging tissues like liver hepatocytes and glial cells, optimizing transfer through envelope protein tweaks such as O-glycosylation alterations for improved efficiency. Recent efforts integrate these platforms with / delivery to selectively knock out host receptors for viruses including and Zika, yielding tools for both antiviral prophylaxis and editable therapies against hereditary diseases. As primary inventor, Sanders holds two U.S. patents on such delivery techniques, underscoring their translational potential. In a May 2020 presentation, Sanders outlined the practical mechanics of employing these modified viruses to introduce nucleic acids into target cells, highlighting their role in scalable protocols.

Efforts in scientific integrity

Development of image forensics methods

David Sanders advanced image forensics in biological research by systematically applying digital analysis to detect manipulations in figures from peer-reviewed papers, emphasizing anomalies common to experimental data like electrophoretic gels, blots, and images. His approach prioritizes identifying duplications—where image segments are copied within or across figures to fabricate replicates—and splicing, where disparate elements are merged to misrepresent results. These methods rely on empirical comparison of pixel-level details, such as matching noise profiles and intensity distributions that deviate from expected biological variability. A key innovation in Sanders' toolkit involves overlaying suspect regions to quantify overlap beyond chance, often revealing identical artifacts or gradients indicative of rather than independent acquisition. For splicing detection, he employs and brightness adjustments to expose seams, irregular textures, or mismatched backgrounds, protocols that highlight manipulations invisible at standard viewing settings. In cases like the retracted "Tin Man Syndrome" study, such techniques uncovered extensive image reuse from unrelated sources, demonstrating their utility in verifying without raw files. Sanders' protocols extend to promoting standardized checks in , including for compression inconsistencies and transforms to flag periodic copy-paste artifacts, fostering community adoption via platforms like . By open-sourcing critiques and methodological rationales, he has elevated image forensics from scrutiny to a replicable practice, reducing reliance on self-reported in high-stakes fields like and .

Investigations into peer misconduct

David Sanders has systematically reported suspected data irregularities, including duplicated or manipulated images, and instances of to scientific journals, focusing on papers published by fellow researchers in and related fields. These reports, initiated as early as 2012, targeted specific evidentiary lapses that undermined the reliability of published findings, such as unauthorized use of a deceased collaborator's data in a co-authored , which prompted its retraction. By , Sanders had flagged concerns in more than two dozen , providing journals with detailed analyses of anomalies like inconsistent bands and textual overlaps, thereby initiating formal review processes without relying on unsubstantiated accusations. His evidence-based submissions emphasized verifiable discrepancies detectable through forensic examination, such as pixel-level inconsistencies in figures, which he argued violated core principles of reproducible science by introducing causal artifacts unrelated to biological phenomena. These efforts extended beyond individual papers to broader patterns, including over 20 instances across multiple authors where he notified editors directly under his own name, urging post-publication audits to prioritize empirical fidelity over institutional inertia. In one notable case, Sanders's alerts to journals about image duplications and plagiarized sections in works from a prominent cancer research group triggered an institutional probe at Ohio State University, culminating in 2022 findings of research misconduct against two lab members for data falsification and plagiarism. Outcomes from these notifications have included targeted corrections, such as the 2017 amendment of a high-profile paper for undisclosed data issues, though Sanders has critiqued journals for inconsistent follow-through, noting persistent failures to retract evidently flawed works despite confirmed institutional misconduct rulings. His approach underscores a commitment to causal accountability in science, where deviations from raw data integrity—often normalized amid publication pressures—erode foundational trust in peer-reviewed literature, prompting calls for journals to adopt rigorous, precedent-agnostic verification standards. Through these processes, Sanders has contributed to heightened scrutiny of normalized lapses, advocating that empirical standards demand proactive correction over passive acceptance of apparent errors.

Impact on retractions and corrections

Sanders' scrutiny of scientific publications has prompted several retractions and corrections, particularly in fields prone to image manipulation such as and . In , his direct complaint to a led to the retraction of a by a former colleague, who had unauthorizedly used microscopy images from a deceased collaborator's prior work without disclosure or permission. Subsequent efforts, including submissions to journals and comments on platforms like , have yielded additional outcomes. For instance, in 2017, allegations of data falsification raised by Sanders contributed to a major correction in a highly cited paper (over 500 citations) by an Ohio State University researcher under institutional investigation. Similarly, long-standing concerns he flagged about duplicated data elements in a 2013 Cell Death & Disease article resulted in its retraction in 2023, after independent notations corroborated the issues. More recently, in 2025, Sanders identified image duplications in a Genentech-authored PNAS paper, prompting an extensive correction for multiple duplications, though he argued the extent of flaws warranted full retraction. These cases illustrate a pattern where Sanders' forensic analyses—focusing on gel bands, blots, and —have driven post-publication reviews, with verifiable journal records confirming actions in at least a handful of instances. His work has also indirectly bolstered field-wide rigor by deterring unsubstantiated claims through public exposure, though comprehensive tallies remain elusive due to fragmented reporting; notes his role in "numerous" such interventions without exhaustive enumeration. Despite occasional institutional hesitance to act decisively on prominent researchers' outputs, the tangible removals and amendments underscore a net positive effect on reliability, emphasizing empirical over reputational preservation.

Conflict with Carlo Croce

David Sanders, an associate professor of biological sciences at , began scrutinizing publications co-authored by Carlo Croce, a leading oncologist at , in 2017. Croce, renowned for his extensive work on microRNAs and their roles in cancer pathogenesis, has co-authored over 1,000 papers garnering hundreds of thousands of citations, including foundational discoveries linking genetic alterations to leukemias and solid tumors. Sanders applied forensic image analysis to Croce's figures, identifying patterns of apparent duplication where the same bands or images were reused across purportedly distinct experiments, as well as splicing artifacts and enhancements inconsistent with raw data standards. These examinations revealed anomalies in at least 20 papers, including instances where lanes appeared cloned or horizontally flipped without disclosure, potentially inflating evidence for protein expression claims central to Croce's hypotheses on regulation. Sanders documented concerns as well, such as unattributed reuse of figures from prior unrelated studies within Croce's oeuvre. His submissions to journals emphasized that such manipulations, detectable via pixel correlation and , violated core principles of , challenging the empirical validity of conclusions in high-impact research. The dispute highlighted vulnerabilities in for prominent labs, where Croce's influence—bolstered by major NIH funding and awards like the 2008 Szent-Györgyi Prize—may have normalized oversight of visual artifacts that first-principles scrutiny deems non-accidental. Sanders' approach prioritized image forensics over trust in institutional gatekeepers, revealing how acceptance of flawed in elite research perpetuates causal misconceptions in cancer biology.

Defamation lawsuit details

In April 2017, Carlo Croce filed a against David Sanders in the U.S. District Court for the Southern District of (Case No. 2:17-cv-00338-JLG-EPD), alleging that Sanders' public statements accusing him of data falsification and in over two dozen co-authored scientific papers constituted and . The complaint specifically targeted Sanders' 2016 administrative complaint to , as well as his disclosures to journalists resulting in articles published in and magazine in March and April 2017, where Sanders described duplicated images suggestive of manipulation in Croce's publications. Sanders moved to dismiss the claims under Ohio's anti-SLAPP statute, arguing that his statements were protected opinions formed through forensic analysis of published figures, not verifiable assertions of fact, and that they advanced public interest in scientific integrity without . Croce opposed, contending the accusations implied undisclosed criminal conduct and were presented as factual findings from Sanders' expertise, supported by an amended complaint adding claims of with based on alleged harm to Croce's professional reputation and funding. Following , including depositions and expert reports on image forensics, Sanders filed for in late 2019, asserting qualified privilege for good-faith reporting of suspected misconduct and lack of evidence for falsity or recklessness. The district court granted the motion on May 12, 2020, ruling that phrases like "falsified data" were non-actionable opinions under law, as they reflected Sanders' subjective interpretation of visual anomalies rather than provable facts, and no genuine dispute existed on Croce's claims. Croce appealed to the U.S. Court of Appeals for the Sixth Circuit (No. 20-3577), reiterating arguments that Sanders' expertise lent factual weight to the statements and that the district court erred in applying opinion protections without a on malice. Sanders countered in his appellate brief that the lower court's analysis aligned with precedents distinguishing rhetorical from , emphasizing the context of peer scrutiny in academia. The Sixth Circuit affirmed the on February 3, 2021, holding that the challenged statements were incapable of defamatory meaning as a matter of .

Outcomes and broader implications

In May 2020, the U.S. District Court for the Southern District of Ohio granted in favor of Sanders, dismissing Croce's claims of and on the grounds that Sanders' statements constituted protected opinion and truthful scientific critique. The U.S. Court of Appeals for the Sixth Circuit affirmed this ruling on February 3, 2021, rejecting Croce's appeal and solidifying Sanders' legal victory without awarding monetary damages, as the case ended in dismissal rather than a . The litigation spanned over three years, imposing substantial non-financial burdens on Sanders, including extensive time diverted from research to defense preparations and investigations into misconduct allegations. Although covered his legal fees, Sanders reported professional setbacks, such as the withdrawal of laboratory resources and perceptions among institutional leadership that his efforts were unwelcome, contributing to heightened and in his academic . This outcome underscores the resilience of empirical scrutiny in legal contexts, where courts prioritized verifiable evidence of data irregularities over reputational defenses, yet highlights systemic risks for academic whistleblowers facing protracted suits that, even when unsuccessful for plaintiffs, extract opportunity costs and deter future critiques. In , where prominent figures often benefit from institutional reluctance to pursue probes—exacerbated by biases favoring continuity over rigorous validation—such cases illustrate how legal tactics can temporarily shield flawed , though ultimate judicial affirmation of factual discourse reinforces the primacy of causal evidence in advancing scientific reliability.

Political involvement

Entry into local politics

David Sanders, an associate professor of biological sciences at , entered local politics in 2015 by seeking election to the West Lafayette City Council as a . His decision reflected a broader application of his scientific emphasis on and rigorous scrutiny—principles he had pursued in exposing research misconduct—to civic issues requiring data-driven governance. Sanders, a long-term resident of West Lafayette, positioned his candidacy as an extension of personal engagement in community matters, drawing on his prior unsuccessful federal campaigns in 2006 and 2008 for U.S. House seats to inform a focus on local representation. In the lead-up to the November 3, , municipal election, Sanders competed for one of three council seats, campaigning on platforms that aligned his expertise in and integrity advocacy with practical local problem-solving. He received support from the County , which endorsed Democratic candidates including Sanders amid a competitive field featuring opponents. This marked his initial shift from national-level bids to municipal , motivated by a desire to address West Lafayette's growth challenges—such as and university-city relations—through verifiable, evidence-based approaches rather than rhetoric. Sanders' entry underscored a rare academic incursion into Tippecanoe County , where Purdue's influence dominates but faculty rarely seek elected roles. By late October 2015, candidate profiles highlighted his 28-year residency and professional background as key qualifiers, emphasizing and in council proceedings. This foray laid the groundwork for subsequent reelection efforts and higher ambitions, framing as an arena for applying first-principles akin to scientific .

Electoral campaigns

Sanders entered electoral politics as the Democratic candidate for an seat on the West Lafayette City Council in the general held on November 3, 2015. Competing against candidates including James Hass, he secured as one of the top vote recipients in the multi-candidate race, assuming office in January 2016. While serving his first term, Sanders announced his candidacy for the Indiana State Senate in District 23 on January 26, 2022, as a . He won the May 3, 2022, primary unopposed and advanced to the general election against Republican Spencer Deery, an aide to President . On November 8, 2022, Deery prevailed with 20,109 votes (63.6 percent) to Sanders's 11,517 votes (36.4 percent).) Sanders sought re-election to the West Lafayette City Council at-large in 2023. In the Democratic primary on May 2, 2023, he advanced with Iris O'Donnell Bellisario and , defeating incumbent . The general election on November 7, 2023, featured the three Democrats against Republican challengers; Sanders placed third in vote totals among all candidates, securing one of the three at-large seats with the Democratic slate sweeping the contest amid 5,694 votes cast in the race. His new term began January 1, 2024, and extends through December 31, 2027.

Policy stances and public positions

Sanders has articulated strong support for , particularly in response to campus protests and calls for ceasefire resolutions at West City Council meetings. In May , during public comments on a proposed urging a and increased U.S. to , he presented a historical overview of Jewish persecution and emphasized the , 2023, attacks as evidence of existential threats to , stating that 's charter explicitly calls for 's destruction and that equating defensive measures with aggression ignores verifiable intent and capabilities for against . This stance prompted walkouts by pro-Palestine attendees, who criticized it as insensitive to Palestinian casualties, though Sanders countered that such reactions often normalize anti- rhetoric without addressing empirical data on rocket attacks and hostage-taking by . In June 2024, Sanders voted against the , contributing to its 5-2 defeat, arguing that resolutions exceed the council's local mandate and risk unbalanced narratives that downplay Israel's security imperatives amid ongoing hostilities. Supporters of his position highlighted alignment with U.S. assessments of Hamas's objectives, while critics, including local activists, accused him of prioritizing one side's security concerns over humanitarian data from , such as reported civilian deaths exceeding 30,000 by mid-2024 per figures, though Sanders maintained that casualty statistics from Hamas-controlled sources warrant scrutiny for inflation tactics observed in prior conflicts. On local development issues, Sanders has opposed rapid rezoning for large-scale projects, voting against the 2025 rezoning for the $3.8 billion semiconductor plant, citing risks to residential , potential environmental strain from industrial expansion, and insufficient mitigation for traffic and water demands despite projected 2,000 jobs. He has similarly voted no on multiple high-rise developments, such as a September 2025 proposal, advocating for measured growth to preserve West Lafayette's community character amid Purdue University's expansion, which has driven population increases of over 5% annually in recent years. Proponents of these projects praised economic multipliers like boosts estimated at $100 million over a decade for , but Sanders defended his votes by referencing data on infrastructure overload in comparable university towns, where unchecked development correlated with higher service costs without proportional benefits. Regarding education, Sanders, as a Purdue biological sciences professor, has supported policies enhancing public access to higher education resources, including council advocacy for zoning adjustments to accommodate student housing without compromising neighborhood stability, though specific votes tie into broader development restraint rather than direct curriculum or funding initiatives. His positions reflect a prioritization of evidence-based governance, drawing from scientific training to evaluate policy impacts empirically, even when facing opposition from growth advocates who argue his caution hinders Indiana's competitiveness in tech sectors.

References

  1. [1]
    David Sanders - Purdue Biological Sciences
    David Sanders, Professional Faculty Research (Molecular virology), Entry of retroviruses and other enveloped viruses into cells; mechanism of enzymatic ...
  2. [2]
    Sanders Lab: Biography - Biological Sciences - Purdue
    Jan 10, 2019 · David Sanders is an Associate Professor of Biological Sciences at Purdue University. He received his Bachelor of Science degree from Yale College.
  3. [3]
    David Sanders Lab - Purdue Biological Sciences
    Aug 22, 2019 · A Purdue University researcher has opened the door for possible antibiotic treatments for a variety of diseases by determining the structure of a protein.
  4. [4]
    David Sanders delivers genes to cells via modified viruses for gene ...
    May 4, 2020 · usp=sharing David Sanders, associate professor in the Department of Biological Sciences at Purdue University, works on introducing genes, or ...
  5. [5]
    David Sanders - Scientific Consultant | LinkedIn
    I work on pandemic preparation and consult about coronaviruses--vaccines, antivirals, videos, and museum displays.
  6. [6]
    A scientist critic was sued, and won — but did not emerge unscathed ...
    Jul 1, 2021 · Sanders, a biologist at Purdue University, has become a scientific sleuth, ferreting out problems in numerous papers.Missing: achievements - | Show results with:achievements -
  7. [7]
    Purdue biologist calls out cases of scientific misconduct
    Mar 22, 2017 · The lack of overall funding is one of the reasons Sanders is so passionate about scientific misconduct, he said. "The fact that they're getting ...Missing: controversies | Show results with:controversies
  8. [8]
    The Rise of the Science Sleuths - Undark Magazine
    Sep 11, 2024 · Likewise, Purdue University biologist David Sanders went public with allegations of potential image manipulation in some articles by famed ...
  9. [9]
    'Each scientist must stand up, at all costs, for the truth' | Times Higher ...
    Jul 9, 2020 · It is those who commit research misconduct – not those who expose them – that damage science, according to David Sanders.Missing: controversies | Show results with:controversies<|separator|>
  10. [10]
    Dr. David Sanders assumes the office of Chair of the University Senate
    Jun 15, 2016 · Prof. David Sanders has assumed the office of Chair of the University Senate. He follows in this role in the footsteps of Prof. Morry Levy. The ...Missing: congress | Show results with:congress
  11. [11]
    Domestic science: when academia and politics collide
    Mar 30, 2023 · Purdue biologist David Sanders ran for election to Indiana's senate last autumn, he assumed a commitment to evidence and personal engagement would give him ...Missing: congress | Show results with:congress
  12. [12]
    David Sanders (Indiana) - Ballotpedia
    David Sanders is an Associate Professor of Biological Sciences at Purdue University. He received his Bachelor of Science degree from Yale College in ...Elections · Campaign themes · See also
  13. [13]
    Guest column: Misplaced emphasis on college sports
    David Sanders. For the Journal & Courier;. The ... The Brooklyn Nets started as the New Jersey Americans in my hometown of Teaneck, N.J. I worked as a ...
  14. [14]
    News Post - Horace Mann School
    Sep 24, 2014 · Dr. Sanders is an Associate Professor of Biological Sciences at Purdue who runs the David Sanders Lab at the University. Discoverer of a ...
  15. [15]
    [PDF] University Senate Document 19-20 23 March 2020 TO
    Mar 23, 2020 · David Sanders is an Associate Professor of Biological Sciences at Purdue University. He received his. Bachelor of Science degree from Yale ...
  16. [16]
    David Sanders - Tessman Symposium - Purdue Biological Sciences
    Dr. Sanders was the discoverer of a biochemical reaction that leads to the entry of cancer-causing retroviruses into cells. His work on the Ebola virus led to ...
  17. [17]
    BIOL 595: Molecular Virology - BoilerClasses
    Course BIOL 595 from Purdue University - West Lafayette.​​ David Sanders has no grade distribution data.Missing: teaching | Show results with:teaching
  18. [18]
    BIOL 31800 - The COVID-19 Pandemic at Purdue University
    Description. Credit Hours: 3.00. The course will cover the COVID-19 pandemic caused by the SARS-CoV-2. · Recent Professors. David Sanders · Recent Semesters. Fall ...
  19. [19]
    'Brews and Brains': Virology banter with a bio professor | Opinions
    Mar 8, 2025 · During the lunch hour on Tuesday, I had the pleasure of sharing a drink with associate professor David Sanders of Purdue's biological sciences ...<|separator|>
  20. [20]
    Purdue professor pursuing city council position | Campus
    Mar 13, 2015 · Sanders, described as having a good sense of humor and quick wit, often pursues interests not customary of a scientist. Besides having a strong ...
  21. [21]
    Sanders Lab: Publications - Biological Sciences - Purdue
    Human immunodeficiency virus type 1 vectors with alphavirus envelope glycoproteins produced from stable packaging cells. J Virol. 79:1765-1771. Sanders, D.A. ...
  22. [22]
    No false start for novel pseudotyped vectors - PubMed
    Author. David Avram Sanders. Affiliation. 1 Department of Biological Sciences, Purdue University, West Lafayette, IN 47907, USA. retrovir@bragg.bio.purdue ...Missing: publications | Show results with:publications
  23. [23]
    Human Immunodeficiency Virus Type 1 Vectors with Alphavirus ...
    Human immunodeficiency virus type 1 (HIV-1) vectors pseudotyped with their glycoproteins could extend the range of tissues that can be transduced in both humans ...<|control11|><|separator|>
  24. [24]
    Role of heparan sulfate in entry and exit of Ross River virus ...
    Role of heparan sulfate in entry and exit of Ross River virus glycoprotein-pseudotyped retroviral vectors ... David Avram Sanders. Show more. Add to Mendeley.Missing: publications | Show results with:publications
  25. [25]
    Researcher hits bulls-eye for antibiotic target - Medical Xpress
    Aug 22, 2006 · Sanders and his collaborator, Miriam Hasson, studied the structure of exopolyphosphatase, a protein in E. coli bacteria that functions as an ...Missing: 2019 | Show results with:2019
  26. [26]
    Purdue researchers develop new delivery system for gene therapy
    Kuhn and David Avram Sanders. Pseudotyped retroviruses have important applications as vectors for gene transfer and gene therapy and as tools for the study ...
  27. [27]
    Ebola virus glycoproteins: guidance devices for targeting gene ...
    Ebola virus glycoproteins: guidance devices for targeting gene therapy vectors ... Author. David A Sanders. Affiliation. 1 Markey Center for Structural ...
  28. [28]
    Sanders Lab: Current Research - Biological Sciences - Purdue
    Aug 22, 2019 · Our most recent laboratory project involves delivering CRISPR technology to cells using viral vectors to knockout viral receptors, specifically ...Missing: virology | Show results with:virology
  29. [29]
    David Sanders - STM Association
    Professor Sanders also is the author of two U.S. patents on novel gene-therapy delivery techniques. His work on the Ebola virus led to his participation in ...Missing: virologist contributions
  30. [30]
    Image duplication in E Galmozzi et al, J Cell Physiol, 200 (2004), pp ...
    Image duplication in E ... Author. David Avram Sanders. Affiliation. 1 Department of biological sciences, Purdue University, West Lafayette, Indiana.Missing: splicing detection protocols
  31. [31]
    Tin Man Syndrome Paper Retracted, Author Admits to Fake Report
    Sep 3, 2025 · A journal has retracted a study on 'Tin Man Syndrome' plagiarized from a decade-old April Fools' joke—which the author now admits was fake.Missing: virologist forensics methods
  32. [32]
    'Tin Man Syndrome' case plagiarized from hoax, sleuths say
    Aug 15, 2025 · ... Tin Man Syndrome.” Unlike the fictitious metal character from ... We asked David Sanders, an image expert and biologist at Purdue ...Missing: type | Show results with:type<|control11|><|separator|>
  33. [33]
    Cancer researcher has dodged accusations for decades (and has a ...
    Mar 8, 2017 · Sanders, a virologist who teaches at Purdue University, has made claims of ... in the midst of an investigation for scientific misconduct. As a ...
  34. [34]
    Science whistleblowers need better support – and I should know
    Oct 11, 2023 · There were numerous examples of image duplications and plagiarism. ADVERTISEMENT. I reported my concerns, in my own name, to the journals ...
  35. [35]
    RESEARCH ARTICLE FORENSICS LEAD TO FINDS OF ...
    Sep 7, 2022 · An investigation prompted by data sleuth David Sanders and conducted by the Ohio State University has led to findings of research misconduct against two ...Missing: controversies | Show results with:controversies
  36. [36]
    Papers in Croce case with “blatantly obvious” problems still aren't ...
    Jul 22, 2022 · Scientists in Carlo Croce's cancer research lab at The Ohio State University had committed research misconduct including plagiarism and data falsification.Missing: Notre Dame
  37. [37]
    OSU researcher under investigation corrects paper cited 500 times
    Jun 9, 2017 · Skip to content. Retraction Watch. Tracking retractions as a window into the scientific ... David Sanders. Like Retraction Watch? Consider making ...
  38. [38]
    Dr. David Sanders on X: "Retracted article @cddpress . Complained ...
    Oct 4, 2023 · Retracted article @cddpress . Complained about it many years ago. Issues also described by someone else in Pubpeer. In violation of @COPE ...
  39. [39]
    Exclusive: Extensive correction to Genentech PNAS article will get ...
    Feb 25, 2025 · Sanders said the original PNAS article “with so many problems” should be retracted. “It simply wasn't valid.” The journal has previously ...
  40. [40]
    Years of Ethics Charges, but Star Cancer Researcher Gets a Pass
    Mar 8, 2017 · Sanders, a virologist who teaches at Purdue University, has made claims of falsified data and plagiarism directly to scientific journals where ...Missing: impact | Show results with:impact
  41. [41]
    Exclusive: investigators found plagiarism and data falsification in ...
    Jul 20, 2022 · But for years, he has faced allegations of plagiarism and falsified images in studies from his group. All told, 11 papers he has co-authored ...
  42. [42]
    Cancer researcher loses defamation suit against critic
    May 13, 2020 · Sanders was quoted and paraphrased several times in connection with his claim that he had found falsified data and plagiarism in scientific ...
  43. [43]
    [PDF] Case: 2:17-cv-00338-JLG-EPD Doc #: 77 Filed - GovInfo
    May 12, 2020 · issue of research misconduct and the failure of scientific journals to adequately address these problems. Dr. Sanders reached out to a ...
  44. [44]
    2008 Szent-Györgyi Prize Winner: Carlo M. Croce, M.D. - NFCR
    The recipient of the 2008 Albert Szent-Györgyi Prize is Carlo M. Croce, M.D. for his groundbreaking discoveries that revolutionized cancer genetics.Missing: prominence | Show results with:prominence
  45. [45]
    CROCE v. SANDERS (2021) - FindLaw Caselaw
    Feb 3, 2021 · Sanders, a virologist who teaches at Purdue University, has made claims of falsified data and plagiarism directly to scientific journals where ...
  46. [46]
    Carlo Croce v. David Sanders, No. 20-3577 (6th Cir. 2021)
    Feb 3, 2021 · In the letter, Glanz named Sanders as the source of the allegations. Glanz's investigation led to a New York Times article about Croce ...
  47. [47]
    Litigious OSU professor loses appeal in federal defamation case
    Feb 4, 2021 · Judge James Graham, of the Southern District of Ohio Eastern Division, ruled against Croce in the case last year. Croce filed an appeal, and ...Missing: virologist outcome<|separator|>
  48. [48]
    At Large Candidate Profiles: David Sanders | City - Purdue Exponent
    Oct 30, 2015 · David Sanders is an associate professor of biological sciences at Purdue University. He is also a long-term resident of West Lafayette.Missing: virologist background Yale Columbia
  49. [49]
    Democratic Congressional Candidate Focuses on Local
    Sep 19, 2006 · David Sanders, Democratic candidate for the U. S. House of Representatives for Indiana District 4 gave a talk in Baxter Hall Monday evening.
  50. [50]
    Election: West Lafayette City Council at-large - Journal & Courier
    Oct 27, 2015 · Candidates: Steven R. Dietrich, Republican. James Hass, Republican. Dave Sturgeon, Republican. David Sanders, Democrat.Missing: announces | Show results with:announces
  51. [51]
    Democrats hold onto control in WL city council - Purdue Exponent
    Nov 3, 2015 · The newly revamped West Lafayette City Council will remain in Democratic control in election results announced Tuesday night.
  52. [52]
    Four New Faces hold positions in West Lafayette City Council
    Nov 4, 2015 · James Hass, Republican at-large candidate, and David Sanders, Democratic at-large candidate, wait for the results of City Council elections on ...Missing: announces | Show results with:announces
  53. [53]
    WL City Council member David Sanders jumps into state Senate race
    Jan 26, 2022 · On Tuesday, David Sanders, a Purdue biology professor and West Lafayette City Council member, guaranteed there will a campaign heading into the ...Missing: congress | Show results with:congress<|separator|>
  54. [54]
    2022 Indiana State Senate - District 23 Election Results
    Candidate, Total Votes, % Votes. Spencer Deery (R), 20,109, 63.6%. David Sanders (D), 11,517, 36.4%. County-By-County Results Map. Democratic Lead.
  55. [55]
    West Lafayette At-Large Council Race decided, Iris O'Donnell ... - WLFI
    Nov 7, 2023 · WEST LAFAYETTE, Ind. · Iris O'Donnell Bellisario, James Blanco, and David Sanders came out with the most votes. · Bellisario led the way with 2006 ...
  56. [56]
    Democrats sweep WL's council at large seats | City & State
    Nov 7, 2023 · Democrats swept West Lafayette's council at large seats Tuesday night, with 5694 votes cast. Overall, the democratic candidates won with ...
  57. [57]
    City Council | West Lafayette, IN - IN.gov
    City Council. Font Size: + -. Share & Bookmark Share & Bookmark, Press Enter ... David Sanders, 01/01/24-12/31/27, Elected. Meeting Information. All Council ...
  58. [58]
    West Lafayette councilman takes a stand for Israel over protestors ...
    May 9, 2024 · By the end of the West Lafayette City Council meeting, the tone of tolerance evaporated as community members walked out after Sanders spoke.
  59. [59]
    West Lafayette City Council meeting gets heated as residents call for ...
    May 7, 2024 · Councilor Sanders continued, “That can also happen in Israel. It could not happen in Hamas-controlled Gaza.” Waves of enraged protesters walked ...
  60. [60]
    Does a Gaza resolution have enough votes in West Lafayette?
    Jun 2, 2024 · + David Sanders, who riled many in the crowd during a May 6 meeting by suggesting Hamas' culpability needed to be considered in the discussion, ...
  61. [61]
    West Lafayette council votes down Gaza ceasefire resolution
    Jun 4, 2024 · "This was one of the many motivating factors for our resolutions.” Bellisario's statement referred to council member David Sanders' presentation ...
  62. [62]
    West Lafayette City Council grapples with question of what's a local ...
    Jun 6, 2024 · “This was one of the many motivating factors for a resolution.” During May's city council meeting, Councilor David Sanders shared a history ...
  63. [63]
    After SK hynix vote, political rumblings in West Lafayette ...
    May 7, 2025 · The lone vote against the rezoning came from David Sanders, who also was among three votes against the residential-to-industrial rezoning for ...
  64. [64]
    West Lafayette City Council rezones land for $3.8 billion chip plant
    May 5, 2025 · Laila Veidemanis, Kathy Parker and David Sanders were the no votes. Michelle Dennis, Colin Lee, Larry Leverenz, Stacey Baitinger Burr, Iris ...
  65. [65]
    Is there an end in sight for high-rise developments in West Lafayette?
    Sep 24, 2025 · ... David Sanders voted no, giving no explanation for his choice in vote before the roll call. But that "no" vote isn't out of the ordinary for ...
  66. [66]
    Thank you for voting no on the Sk Hynix and IEDC decision
    Dec 3, 2024 · The lone vote against the measure came from city council member David Sanders. Sanders said SK hynix's plans – including production of high ...Missing: education | Show results with:education
  67. [67]
    Meet the Candidates: City Council | City & State | purdueexponent.org
    Nov 5, 2023 · ... West Lafayette. David Sanders (D) - Council at Large. Why are you running for West Lafayette City Council? I believe in public service. My ...<|separator|>